Macarena De La Fuente, Md

Researchers are studying lixumistat, an experimental oral drug, in adults with newly diagnosed glioblastoma who are scheduled for surgery to remove their tumor. Participants take lixumistat once daily for up to four days before surgery, with dosing possibly extended to six days i…